Prosecution Insights
Last updated: October 21, 2026

Evermore Chemical Industry Co. Ltd.

Technology area: Chemistry & Materials

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Evermore Chemical Industry Co. Ltd. currently has 1 pending office action in the Chemistry & Materials technology area. This application is assigned to 1 distinct examiner, showing a focused approach to the company's current legal matters. This concentration allows for a unified and consistent technical argument to be presented, which can be particularly effective in the chemistry sector where technical details are critical. Such a strategy ensures that the company's innovations are clearly distinguished from the prior art in a way that the examiner can easily understand.

The portfolio is active in a distinct art unit, indicating a specific technical focus for the pending matter. BELUNIS, THOMAS JAMES, is the busiest examiner, currently overseeing the pending office action. The company must successfully address the specific prior art cited by this examiner to advance its portfolio. Practitioners should analyze the examiner's history with similar chemical technologies to craft the most persuasive arguments for patentability and to anticipate any potential hurdles in the prosecution process.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BELUNIS, THOMAS JAMES 1 — —

Top Art Units

Art UnitApps
1767 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18428196 THERMOPLASTIC POLYURETHANE FOAM MATERIAL, MIDSOLE OF ATHLETIC SHOE AND MANUFACTURING METHOD OF FOAM MATERIAL BELUNIS, THOMAS JAMES 1767 §103 Non-Final OA — Pending Jan 31, 2024

Managing Evermore Chemical Industry Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Evermore Chemical Industry Co. Ltd. have?

Evermore Chemical Industry Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Evermore Chemical Industry Co. Ltd. applications?

Thomas James Belunis has the most, with 1 of Evermore Chemical Industry Co. Ltd.'s pending office actions.

What technology area are Evermore Chemical Industry Co. Ltd.'s patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month